Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

A.W MEDICAL OFFICE, P.C

NPI: 1235316563 · BRONX, NY 10453 · Internal Medicine Physician · NPI assigned 01/29/2008

$223K
Total Medicaid Paid
210,379
Total Claims
202,470
Beneficiaries
86
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTALLAJ, RAMON (PHYSICIAN)
NPI Enumeration Date01/29/2008

Related Entities

Other providers sharing the same authorized official: TALLAJ, RAMON

ProviderCityStateTotal Paid
ACADEMY MEDICAL CARE PC NEW YORK NY $283K
BALANCE MEDICAL PROFESSIONAL PRIMARY SERVICES PLLC BRONX NY $99K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 28,875 $105K
2019 35,303 $76K
2020 18,245 $12K
2021 26,039 $18K
2022 28,017 $4K
2023 36,573 $7K
2024 37,327 $1K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8,473 8,119 $89K
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 3,673 3,671 $36K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 2,354 2,353 $16K
93000 857 854 $12K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,162 1,157 $11K
H0001 Alcohol and/or drug assessment 12,978 12,484 $9K
3078F 7,664 7,446 $8K
3074F 6,093 5,985 $6K
90658 997 993 $6K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,165 1,152 $4K
99406 309 294 $3K
90688 164 164 $2K
3077F 1,036 1,018 $2K
99442 588 574 $2K
36415 Collection of venous blood by venipuncture 7,240 6,868 $2K
1170F 2,524 2,418 $2K
0011A 46 46 $2K
82948 3,672 3,530 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 281 281 $1K
0012A 32 32 $1K
1125F 2,029 1,976 $890.35
3075F 1,213 1,205 $810.76
99441 415 413 $621.59
1160F 3,301 3,100 $540.00
3079F 494 487 $525.59
1126F 4,997 4,842 $429.78
1159F 2,966 2,765 $425.03
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 277 277 $276.50
99386 25 25 $159.18
G8510 Screening for depression is documented as negative, a follow-up plan is not required 9,254 8,871 $74.75
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 89 89 $46.98
3044F 1,370 1,342 $40.74
G9622 Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method 11,908 11,458 $8.51
3008F 9,163 8,816 $3.60
3061F 1,237 1,205 $0.99
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 3,962 3,727 $0.67
G9621 Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling 184 180 $0.62
2022F 469 451 $0.44
1157F 2,475 2,474 $0.05
3045F 13 13 $0.03
3060F 25 25 $0.03
3048F 854 832 $0.01
S0257 Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) 57 57 $0.01
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 4,694 4,501 $0.00
G9276 Documentation that patient is a current tobacco user 239 229 $0.00
2028F 2,795 2,682 $0.00
0518F 2,898 2,779 $0.00
3725F 8,510 8,197 $0.00
3288F 2,921 2,799 $0.00
3016F 9,116 8,775 $0.00
3050F 279 273 $0.00
G9507 Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) 2,391 2,206 $0.00
G9820 Documentation of a chlamydia screening test with proper follow-up 224 211 $0.00
4013F 1,751 1,619 $0.00
99397 44 44 $0.00
3015F 108 99 $0.00
G9899 Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed 146 137 $0.00
1175F 15 15 $0.00
1494F 25 25 $0.00
1090F 25 25 $0.00
G9275 Documentation that patient is a current non-tobacco user 11,894 11,446 $0.00
0001F 480 453 $0.00
1000F 9,042 8,699 $0.00
2001F 885 861 $0.00
3017F 2,367 2,264 $0.00
4293F 9,151 8,806 $0.00
4010F 1,261 1,158 $0.00
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 2,395 2,210 $0.00
2010F 8,525 8,200 $0.00
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 107 100 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 3,735 3,591 $0.00
G8734 Elder maltreatment screen documented as negative, follow-up is not required 55 55 $0.00
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 1,572 1,457 $0.00
82043 109 109 $0.00
3014F 1,480 1,439 $0.00
1005F 802 778 $0.00
3049F 398 379 $0.00
G0202 Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed 253 245 $0.00
1101F 526 492 $0.00
91301 94 94 $0.00
96127 125 124 $0.00
2000F 494 464 $0.00
99443 159 158 $0.00
G8418 Bmi is documented below normal parameters and a follow-up plan is documented 38 38 $0.00
1034F 88 87 $0.00
82962 78 78 $0.00